Practitioners who purchase ProHeart 6 will also be required to communicate with pet owners about the benefits and risks associated with the product. This will include providing pet owners with a Client Information Sheet and answering all client questions, as well as obtaining a signed "Informed Consent" form from the pet owner before the product is administered.
"While Fort Dodge and other veterinary professionals have worked diligently during the past few years to generate additional safety data to support the return of ProHeart 6 to the U.S. market, this accomplishment would not have been possible without the support of countless veterinarians and pet owners who truly believe in this product and recognize the benefits it brings to the dogs in our lives," says Dr. Cobb.
Fort Dodge Animal Health is a leading manufacturer and marketer of animal health products for the livestock, companion animal, equine, swine and poultry industries in North America and international markets. Key products include West Nile-Innovator(R), CYDECTIN(R) Pour-On, the Duramune(R) and Fel-O-Vax(R) vaccine lines, and QUEST(R) and QUEST(R) Plus Gel. The company has research and development facilities in Iowa and New Jersey, and manufacturing facilities/offices in Brazil, Argentina, Spain, Ireland, France, The Netherlands, Italy, India, Taiwan and Australia. Its headquarters is in Overland Park, Kan.
About Heartworm Disease
Heartworm disease is a potentially deadly disease affecting the U.S.
canine population. Spread by mosquitoes, it can cause seriou
'/>"/>
| SOURCE Fort Dodge Animal Health Copyright©2008 PR Newswire. All rights reserved |